LymeX Authorization Act

This legislation authorizes the Secretary of Health and Human Services to fund prize competitions specifically designed to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease. The policy aims to engage a broad range of stakeholders, including academia, industry, and nonprofits, to facilitate patient-centered advancements in care. Key objectives include fostering breakthroughs in health education and public awareness, alongside accelerating the development of rapid and patient-focused next-generation diagnostics . To achieve these goals, the bill authorizes an appropriation of $5,000,000 for these prize competitions, ultimately seeking to improve outcomes for individuals affected by Lyme disease.